Add To Watchlist
Share URL
About The Company
CEO
Mr. Edward Manolos
Market Cap
284.11 Thousand USD
Sector
Healthcare
Website
https://www.cannabisglobalinc.comDescription
Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.
Read More
Overview
Value
50
Growth
32
Health
42
Management
35
Analyst Opinion
69
Total
46
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a margin-of-safety above fair value
- Low preportion of income is paid as dividend
Risk Factors
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders 0
- Does not hold enough liquid assets to cover short term liabilities
- Poor earnings and cashflow growth 0
Latest News
Cannabis Global, Hub Craft & Active Health Foods To Develop California Cannabis MSO
Benzinga | 18:56 Wed 5 Jan 2022
Read More →

Cannabis Global Reports Significantly Increased Revenues And Lots Of New Products For 2022
Benzinga | 22:02 Thu 16 Dec 2021
Read More →

Cannabis Global's Shares Up, Announces Research Into Psychedelic Mushroom Infusions In Food & Beverage
Benzinga | 16:40 Thu 4 Nov 2021
Read More →

Cannabis Global Goes Live! - Introduces Live Rosin Cannabis Products to the California Marketplace
Accesswire | 14:00 Tue 19 Oct 2021
Read More →
Market Peers
CBGL
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
2363.72%
Revenue Growth (5 Year Average)
N/A
Ratings Consensus
Buy
Share Buybacks
-33.95%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
50
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✔
Current Price: 0 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-345.83%
PE/Earnings Growth
N/A
Price/Book
0.04x
Growth
Growth Score
32
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 19.75% is higher than the market average (14.48%)
- ✔ Earnings growth has improved this year
- ✔ Free Cashflow growth has improved this year
- ✘ 5 Year Average Revenue growth of N/A is lower than the market average (10.97%)
- ✘ 5 Year Average Free Cashflow growth of -6.46% is lower than the market average (12.35%)
Revenue Growth
N/A
Earnings Growth
19.75%
Cashflow Growth
-6.46%
Health
Health Score
42
Altman Z Score
N/A
Piostroski Score
4.00
Debt/Equity
1.32x
Current Assets/Liabilities
0.21x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
3.37x
Management
Management Score
35
Average Buybacks/Dilution
-33.95%
Recent Buybacks/Dilution
9.96%
5 Year Price Volitility
122.98%
Return On Assets
-4.57%
Return On Capital Employed
0.30%
Return On Equity
-21.22%
Return On Free Cashflow
202.04%
Return On Investments
-95.50%
Analysts
Analyst Opinion
69
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Cannabis Global, Inc.
Currency
USD
Beta
0.839204
Vol Avg
15617890
Ceo
Mr. Edward Manolos
Cik
0001413488
Cusip
13767G100
Exchange
Other OTC
Full Time Employees
3
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
2008-06-19
Address
520 South Grand Avenue
City
Los Angeles
State
CA
Country
US
Zip
90071
Phone
310 986 4929
All financial data provided by FMP